Searched for
PHARMA BUSINESS
Mumbai felt safer than US: NRI returns to India after 23 years, shares why he left the American DreamAn NRI who spent 23 years in the US has shared why he eventually moved back to Mumbai, saying he "felt safer" there. After building a caree...- European pharma chiefs warn region risks losing ground to America, ChinaDrugmakers for months have been warning they could curtail investments and delay the release of new medications in Europe, widening a dispa...
- Economy’s swell, but reputation? Why India’s next growth story depends on how the world sees itIndia’s long-term economic prospects remain strong despite short-term geopolitical, currency and capital-flow challenges. As the country’s ...
- CAS chaos: Nifty’s indicative price drops 1% in seconds to fall below 23,150 on F&O expiry day, Sensex closes 330 pts lowerIndian equities ended lower on Tuesday after morning gains faded, with Sensex dropping 330 points and Nifty witnessing a sharp closing-auct...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- Factory floor or family office? India’s young rich alarm eldersIndia’s wealthy business families are increasingly shifting from traditional family businesses to family offices, private equity and startu...
- Ichor Biologics seeks $80-100 million PE funding for minority stake saleIchor Biologics is seeking eighty to one hundred million dollars from private equity investors. The Hyderabad-based company operates in the...
- Aragen steps up investment in complex drug modalities; plans 500 KL new CDMO capacityAragen Life Sciences is increasing investments in complex drug modalities and manufacturing. The company plans to add significant small-mol...
- Cash-flow-based lending to become important for new-age sectors: SBI MDAs new industries emerge, cash-flow-based lending is poised to play a pivotal role in their growth. With traditional collateral often absen...
- ET Startup Awards 2026: Theranautilus’ nanorobots will be ready for human trials by year-endTheranautilus won the Top Innovator category at The Economic Times Startup Awards 2026 for its unique nanorobot technology, which is built ...
- Yatharth Hospitals shares rally 10% to fresh record high as Advent set to acquire 25% stake; stock up 20% in two daysYatharth Hospital shares surged over 10% after Advent International announced a Rs 3,150-crore investment for a 24.9% stake in the hospital...
- 3 smallcap mutual funds returned over 23% in 2026. These 5 stocks feature in all their portfoliosIn 2026, three smallcap mutual funds delivered remarkable returns exceeding twenty-three percent. Notably, these outstanding funds uniforml...
- EQT Group plans to invest $50 billion in India by 2030: Jean Eric Salata, ChairmanSwedish buyout firm EQT plans to invest $50 billion in India over the next four years, roughly twice the $26 billion it has invested since ...
- JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...
- Quant Mid Cap Fund exits ICICI Bank, 2 others and adds 5 stocks in AugustQuant Mid Cap Fund exited ICICI Bank, Ambuja Cements and L&T Technology Services in August, while adding six stocks including IDBI Bank, Co...
- MFs raise healthcare bets for 4th straight month to 71-month high. Should investors follow?Mutual funds raised their healthcare allocation for the fourth straight month in August 2026 to 8.4%, the highest in 71 months. Experts att...
- Stocks in news: Yes Bank, Vedanta, Groww, BHEL, Bharat Forge and NBCCIndian equity markets closed lower on Tuesday, extending their monthly decline. Nifty50 reached a key support level, indicating a potential...
- India’s PE market turns tougher as buyers seek more protection: Khaitan & Co SurveyIndian private equity buyers now demand greater seller protection and price adjustments. Purchase price adjustments rose significantly, ref...
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun BeveragesOn September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...
- Sun Pharma gets ratings boost from Moody's, S&P over USD 11.75-bn Organon & Co acquisition bidRating agencies Moody's and S&P assigned investment-grade ratings to Sun Pharmaceutical Industries. This action follows Sun Pharma's propos...
Load More
